Update on Antithrombotic Therapy New Anticoagulants

被引：192

作者：

Eikelboom, John W. ^{[2
]}

Weitz, Jeffrey I. ^{[1
,2
,3
]}

机构：

[1] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada

[2] McMaster Univ, Dept Med, Hamilton, ON, Canada

[3] Dept Biochem & Med Sci, Hamilton, ON, Canada

来源：

CIRCULATION | 2010年 / 121卷 / 13期

关键词：

anticoagulants; antithrombotic therapy; ACUTE CORONARY SYNDROMES; TOTAL HIP-REPLACEMENT; DIRECT THROMBIN INHIBITOR; TOTAL KNEE REPLACEMENT; ORAL DIRECT THROMBIN; FACTOR-XA INHIBITOR; MOLECULAR-WEIGHT HEPARIN; VITAMIN-K ANTAGONISTS; NON-INFERIORITY TRIAL; FACTOR-IXA ACTIVITY;

D O I：

10.1161/CIRCULATIONAHA.109.853119

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1523 / 1532

页数：10

共 49 条

[1] Pharmacology and management of the vitamin K antagonists
Ansell, Jack
Hirsh, Jack
Hylek, Elaine
Jacobson, Alan
Crowther, Mark
Palareti, Gualtiero
[J]. CHEST, 2008, 133 (06) : 160S - 198S
[2] Outbreak of Adverse Reactions Associated with Contaminated Heparin
Blossom, David B.
Kallen, Alexander J.
Patel, Priti R.
Elward, Alexis
Robinson, Luke
Gao, Ganpan
Langer, Robert
Perkins, Kiran M.
Jaeger, Jennifer L.
Kurkjian, Katie M.
Jones, Marilyn
Schillie, Sarah F.
Shehab, Nadine
Ketterer, Daniel
Venkataraman, Ganesh
Kishimoto, Takashi Kei
Shriver, Zachary
McMahon, Ann W.
Austen, K. Frank
Kozlowski, Steven
Srinivasan, Arjun
Turabelidze, George
Gould, Carolyn V.
Arduino, Matthew J.
Sasisekharan, Ram
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (25) : 2674 - 2684
[3] Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3
[4] Buller HR, 2007, NEW ENGL J MED, V357, P1105
[5] Buller HR, 2007, NEW ENGL J MED, V357, P1094
[6] Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Chan, Mark Y.
Cohen, Mauricio G.
Dyke, Christopher K.
Myles, Shelley K.
Aberle, Laura G.
Lin, Min
Walder, James
Steinhubl, Steven R.
Gilchrist, Ian C.
Kleiman, Neal S.
Vorchheimer, David A.
Chronos, Nicholas
Melloni, Chiara
Alexander, John H.
Harrington, Robert A.
Tonkens, Ross M.
Becker, Richard C.
Rusconi, Christopher P.
[J]. CIRCULATION, 2008, 117 (22) : 2865 - 2874
[7] Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Connolly, Stuart J.
Pogue, Janice
Eikelboom, John
Flaker, Gregory
Commerford, Patrick
Franzosi, Maria Grazia
Healey, Jeffrey S.
Yusuf, Salim
[J]. CIRCULATION, 2008, 118 (20) : 2029 - 2037
[8] Challenges of establishing new antithrombotic therapies in atrial fibrillation
Connolly, Stuart J.
Eikelboom, John
O'Donnell, Martin
Pogue, Janice
Yusuf, Salim
[J]. CIRCULATION, 2007, 116 (04) : 449 - 455
[9] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Connolly, Stuart J.
Ezekowitz, Michael D.
Yusuf, Salim
Eikelboom, John
Oldgren, Jonas
Parekh, Amit
Pogue, Janice
Reilly, Paul A.
Themeles, Ellison
Varrone, Jeanne
Wang, Susan
Alings, Marco
Xavier, Denis
Zhu, Jun
Diaz, Rafael
Lewis, Basil S.
Darius, Harald
Diener, Hans-Christoph
Joyner, Campbell D.
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
[10] First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity
Dyke, Christopher K.
Steinhubl, Steven R.
Kleiman, Neal S.
Cannon, Richard O.
Aberle, Laura G.
Lin, Min
Myles, Shelley K.
Melloni, Chiara
Harrington, Robert A.
Alexander, John H.
Becker, Richard C.
Rusconi, Christopher P.
[J]. CIRCULATION, 2006, 114 (23) : 2490 - 2497

← 1 2 3 4 5 →